Generic for Mavik: An Overview
Mavik® (
trandolapril) is a prescription medication that has been licensed to treat
high blood pressure (
hypertension) and
congestive heart failure or left ventricular dysfunction following a
heart attack. Mavik is part of a class of drugs called angiotensin-converting enzyme inhibitors, or ACE inhibitors for short. Mavik helps to block the angiotensin-converting enzyme, which is normally part of a reaction in the body that causes blood vessels to narrow (constrict). By blocking this enzyme, Mavik causes blood vessels to relax, which can
lower blood pressure. It also allows the heart to work more efficiently.
Mavik was originally developed by Abbott Laboratories. However, the patent for Mavik has expired, and Mavik is available as a generic.
Strengths of Generic Mavik
Generic Mavik tablets are available in the following strengths:
- Trandolapril 1 mg
- Trandolapril 2 mg
- Trandolapril 4 mg.
Generic Mavik is made by the following manufacturers:
- AuroBindo Pharma
- Cobalt Laboratories
- Lupin Pharmaceuticals
- Sandoz Pharmaceuticals
- Teva Pharmaceuticals
- West-ward Pharmaceuticals.
Is Generic Trandolapril as Good as Mavik?
All generic medications must undergo certain tests to compare them to brand-name medications.
The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic trandolapril versions currently available have an "AB" rating, meaning they should be equivalent to Mavik.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers or dyes or other ingredients that may cause problems for people with
allergies or sensitivities.